The expression of LAT1 is increased in various cancers, such as clear cell renal cell carcinoma, colorectal cancer, endometroid carcinoma, gastric cancer, prostate cancer, esophageal cancer, NSCLC, and pancreatic cancer [102,103,104,105,106,107,108,109]. Here, SLC7A5 is linked to cancer.